Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Protein biomarker discovery for head and neck cancer.

Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ, Slijper M.

J Proteomics. 2010 Sep 10;73(10):1790-803. doi: 10.1016/j.jprot.2010.01.013. Epub 2010 Feb 4. Review.

PMID:
20139037
[PubMed - indexed for MEDLINE]
2.

Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.

Lee KD, Lee HS, Jeon CH.

Anticancer Res. 2011 Apr;31(4):1161-7. Review.

PMID:
21508360
[PubMed - indexed for MEDLINE]
3.

[Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck].

Al Kassam D, Alvarez Marcos C, Blanco I, de Los Toyos JR, Llorente JL.

Med Clin (Barc). 2007 Dec 1;129(20):761-5. Spanish.

PMID:
18093475
[PubMed - indexed for MEDLINE]
4.

Head and neck cancer: meeting summary and research opportunities.

Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA, Mohla S.

Cancer Res. 2004 Nov 1;64(21):8126-9.

PMID:
15520225
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.

Colnot DR, Nieuwenhuis EJ, Kuik DJ, Leemans CR, Dijkstra J, Snow GB, van Dongen GA, Brakenhoff RH.

Clin Cancer Res. 2004 Dec 1;10(23):7827-33.

PMID:
15585614
[PubMed - indexed for MEDLINE]
Free Article
6.

Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer.

Chen ZG.

Curr Cancer Drug Targets. 2007 Nov;7(7):613-22. Review.

PMID:
18045066
[PubMed - indexed for MEDLINE]
7.

Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.

Sepiashvili L, Hui A, Ignatchenko V, Shi W, Su S, Xu W, Huang SH, O'Sullivan B, Waldron J, Irish JC, Perez-Ordonez B, Liu FF, Kislinger T.

Mol Cell Proteomics. 2012 Nov;11(11):1404-15. doi: 10.1074/mcp.M112.020933. Epub 2012 Aug 23.

PMID:
22918226
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

Marimuthu A, Chavan S, Sathe G, Sahasrabuddhe NA, Srikanth SM, Renuse S, Ahmad S, Radhakrishnan A, Barbhuiya MA, Kumar RV, Harsha HC, Sidransky D, Califano J, Pandey A, Chatterjee A.

Biochim Biophys Acta. 2013 Nov;1834(11):2308-16. doi: 10.1016/j.bbapap.2013.04.029. Epub 2013 May 7.

PMID:
23665456
[PubMed - indexed for MEDLINE]
9.

Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis.

Schaaij-Visser TB, Brakenhoff RH, Jansen JW, O'Flaherty MC, Smeets SJ, Heck AJ, Slijper M.

J Proteomics. 2009 Jul 21;72(5):803-14. doi: 10.1016/j.jprot.2009.05.001. Epub 2009 May 13.

PMID:
19446051
[PubMed - indexed for MEDLINE]
10.

The stem cell hypothesis in head and neck cancer.

Graziano A, d'Aquino R, Tirino V, Desiderio V, Rossi A, Pirozzi G.

J Cell Biochem. 2008 Feb 1;103(2):408-12. Review.

PMID:
17546610
[PubMed - indexed for MEDLINE]
11.

Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.

Califano J, Westra WH, Koch W, Meininger G, Reed A, Yip L, Boyle JO, Lonardo F, Sidransky D.

J Natl Cancer Inst. 1999 Apr 7;91(7):599-604.

PMID:
10203278
[PubMed - indexed for MEDLINE]
Free Article
12.

Clinical significance of head and neck squamous cell cancer biomarkers.

Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R, Masarik M.

Oral Oncol. 2014 Mar;50(3):168-77. doi: 10.1016/j.oraloncology.2013.12.008. Epub 2013 Dec 29. Review.

PMID:
24382422
[PubMed - indexed for MEDLINE]
13.

Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.

Bongers V, Snow GB, de Vries N, Cattan AR, Hall AG, van der Waal I, Braakhuis BJ.

Lab Invest. 1995 Oct;73(4):503-10.

PMID:
7474922
[PubMed - indexed for MEDLINE]
14.

Evolving 'omics' technologies for diagnostics of head and neck cancer.

Nagaraj NS.

Brief Funct Genomic Proteomic. 2009 Jan;8(1):49-59. doi: 10.1093/bfgp/elp004. Epub 2009 Mar 9. Review.

PMID:
19273537
[PubMed - indexed for MEDLINE]
Free Article
15.

Molecular assay to detect metastatic head and neck squamous cell carcinoma.

Becker MT, Shores CG, Yu KK, Yarbrough WG.

Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):21-7.

PMID:
14732763
[PubMed - indexed for MEDLINE]
16.

[Tumor markers and biomarkers in squamous cell cancer of the head and neck].

Lordick F, Krauss J, Jäger D.

HNO. 2008 Sep;56(9):881-5. doi: 10.1007/s00106-008-1762-6. Review. German.

PMID:
18696018
[PubMed - indexed for MEDLINE]
17.

Ninein-like protein is overexpressed in head and neck squamous cell carcinoma and contributes to cancer growth and resistance to apoptosis.

Yu L, Song Y, Zhang Q, Zhan Q.

Oncol Rep. 2009 Oct;22(4):789-98.

PMID:
19724857
[PubMed - indexed for MEDLINE]
18.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Epub 2007 May 4. Review.

PMID:
17482300
[PubMed - indexed for MEDLINE]
19.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
[PubMed - indexed for MEDLINE]
20.

Squamous cell carcinoma of the head and neck in the elderly.

Koch WM, Patel H, Brennan J, Boyle JO, Sidransky D.

Arch Otolaryngol Head Neck Surg. 1995 Mar;121(3):262-5.

PMID:
7873140
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk